MF
NVCR icon

Magnetar Financial’s NovoCure NVCR Stock Holding History

Magnetar Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,293
Closed -$112K – 1381
2026
Q1 		$112K Buy
+10,293
New +$129K ﹤0.01% 994
2023
Q1 		– Sell
-3,296
Closed -$242K – 685
2022
Q4 		$242K Buy
+3,296
New +$248K ﹤0.01% 672
2017
Q2 		– Sell
-15,272
Closed -$124K – 916
2017
Q1 		$124K Buy
+15,272
New +$110K ﹤0.01% 695
2016
Q4 		– Sell
-12,216
Closed -$104K – 275
2016
Q3 		$104K Buy
+12,216
New +$111K ﹤0.01% 530

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Magnetar Financial's NVCR Position: Q2 2026 in Review

Magnetar Financial sold out of NovoCure (NVCR) in Q2 2026, closing a stake of 10,293 shares — an estimated $112K sold.

Magnetar Financial first reported a position in NVCR in Q3 2016 and held it in 4 quarters. The position peaked at $242K in Q4 2022. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Magnetar Financial reported no remaining NovoCure position as of Q2 2026 after selling out during the quarter.
  • Magnetar Financial sold 10,293 NovoCure shares in Q2 2026, an estimated $112K.
  • Magnetar Financial first reported a position in NovoCure in Q3 2016 and held it in 4 quarters.
  • Magnetar Financial's NovoCure position peaked at $242K in Q4 2022.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.